Azithromycin for pneumonia
Azithromycin has been associated with increased cardiovascular events, but a new study suggests that it may be safe for treating older patients with pneumonia. In a study from the Veterans Administration acute care hospital system, nearly 32,000 adults ≥ 65 years who were hospitalized for pneumonia and treated with azithromycin were matched with 32,000 who were on a “guideline-concordant regimen” that did not include azithromycin. Outcomes included 30- and 90-day all-cause mortality and heart-related mortality as well as cardiac events. Mortality at 90 days was significantly lower in the group treated with azithromycin (17.4% vs 22.3%, odds ratio, 0.73; 95% CI, 0.70-0.76). There was a higher rate of MI, but no increase in overall cardiac events with azithromycin. The authors conclude that among older patients hospitalized with pneumonia, a treatment regimen that includes azithromycin was associated with a lower 90-day mortality and a smaller increased risk of MI (JAMA 2014;311:2199-2208).
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.